RAYMOND JAMES & ASSOCIATES - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 164 filers reported holding BLUEBIRD BIO INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q2 2023$46,445
+2.4%
14,117
-1.0%
0.00%
Q1 2023$45,344
-50.6%
14,259
+7.5%
0.00%
Q4 2022$91,752
+6.7%
13,259
-2.5%
0.00%
Q3 2022$86,000
+72.0%
13,604
+32.7%
0.00%
Q1 2022$50,000
-93.9%
10,254
-45.8%
0.00%
-100.0%
Q4 2020$818,000
-40.0%
18,909
-25.1%
0.00%
-50.0%
Q3 2020$1,363,000
+13.5%
25,261
+28.4%
0.00%0.0%
Q2 2020$1,201,000
+278.9%
19,676
+184.8%
0.00%
+100.0%
Q1 2020$317,000
-45.6%
6,908
+3.9%
0.00%0.0%
Q4 2019$583,000
+32.8%
6,649
+39.2%
0.00%0.0%
Q3 2019$439,000
-21.9%
4,777
+8.2%
0.00%0.0%
Q2 2019$562,000
-15.1%
4,415
+5.0%
0.00%0.0%
Q1 2019$662,000
+109.5%
4,205
+31.8%
0.00%0.0%
Q4 2018$316,000
-10.5%
3,190
+32.0%
0.00%0.0%
Q3 2018$353,000
-38.6%
2,416
-34.1%
0.00%0.0%
Q2 2018$575,000
-15.8%
3,666
-8.3%
0.00%0.0%
Q1 2018$683,000
-20.1%
3,998
-16.7%
0.00%
-50.0%
Q4 2017$855,000
+65.7%
4,801
+27.8%
0.00%
+100.0%
Q3 2017$516,000
+149.3%
3,756
+90.2%
0.00%
Q2 2017$207,000
-6.3%
1,975
-18.7%
0.00%
-100.0%
Q1 2017$221,0002,4290.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 1,834,965$35,066,0001.72%
Birchview Capital, LP 84,000$1,605,0001.09%
ARMISTICE CAPITAL, LLC 2,472,000$47,240,0000.80%
EcoR1 Capital, LLC 802,507$15,336,0000.53%
Parametrica Management Ltd 36,919$706,0000.53%
Bain Capital Life Sciences Investors, LLC 538,179$7,239,0000.45%
APPLETON GROUP, LLC 19,495$373,0000.32%
MANGROVE PARTNERS IM, LLC 175,587$3,355,0000.30%
Quinn Opportunity Partners LLC 230,100$4,397,0000.28%
PDT Partners, LLC 171,700$3,281,0000.24%
View complete list of BLUEBIRD BIO INC shareholders